The Signal
THE SIGNAL

Where Web3 founders, talent, and partners meet.

Daily Digest · Free
PLATFORM
  • Partners Directory
  • All Categories
  • Marketplace
  • Find a Partner
  • Docs
  • Escrow
INTELLIGENCE
  • Web3 News
  • Daily Digests
  • Intel Reports
  • Web3 Events
  • RSS Feed
  • Substack ↗
GET INVOLVED
  • Get Listed
  • Get Your Verified Badge
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Book a Call
COMPANY
  • About
  • How It Works
  • Manifesto
  • Media Kit
  • Privacy
  • Terms
© 2026 THE SIGNAL · All rights reserved.Operated by Nomdon Tech Ltd · No. 15462747 · England
PRIVACYTERMSCOOKIES
THE SIGNAL
The Signal
THE SIGNAL

Where Web3 founders, talent, and partners meet.

Daily Digest · Free
PLATFORM
  • Partners Directory
  • All Categories
  • Marketplace
  • Find a Partner
  • Docs
  • Escrow
INTELLIGENCE
  • Web3 News
  • Daily Digests
  • Intel Reports
  • Web3 Events
  • RSS Feed
  • Substack ↗
GET INVOLVED
  • Get Listed
  • Get Your Verified Badge
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Book a Call
COMPANY
  • About
  • How It Works
  • Manifesto
  • Media Kit
  • Privacy
  • Terms
© 2026 THE SIGNAL · All rights reserved.Operated by Nomdon Tech Ltd · No. 15462747 · England
PRIVACYTERMSCOOKIES
THE SIGNAL
The Signal Logo
THE SIGNAL
Offers
POST A BRIEF
JOIN AS PARTNER
News
Novo Nordisk Wegovy Pill Launches, Expanding Acces...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Signal TakeNeutral
AltcoinsRegulationTrading

Novo Nordisk has launched a $149 Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this once-daily pill provides an alternative to injectable treatments, which have seen significant demand. The development aims to broaden access to weight-loss drugs.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Spot HYPE ETFs near $900 million in volume as early demand signals institutional interest

The Block•8h ago

Elon Musk Loses Again to OpenAI as Judge Dismisses xAI Trade Secret Lawsuit

Decrypt •8h ago

Pudgy Penguins NFT Game 'Pudgy Party' Shuts Down Less Than a Year After Launch

Decrypt •9h ago

Nvidia’s $20 billion debt boom reinforces Bitcoin miners' AI pivot

Cointelegraph•9h ago
← Back to News Feed
The Signal Logo
THE SIGNAL
Offers
POST A BRIEF
JOIN AS PARTNER
News
Novo Nordisk Wegovy Pill Launches, Expanding Acces...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Signal TakeNeutral
AltcoinsRegulationTrading

Novo Nordisk has launched a $149 Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this once-daily pill provides an alternative to injectable treatments, which have seen significant demand. The development aims to broaden access to weight-loss drugs.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Spot HYPE ETFs near $900 million in volume as early demand signals institutional interest

The Block•8h ago

Elon Musk Loses Again to OpenAI as Judge Dismisses xAI Trade Secret Lawsuit

Decrypt •8h ago

Pudgy Penguins NFT Game 'Pudgy Party' Shuts Down Less Than a Year After Launch

Decrypt •9h ago

Nvidia’s $20 billion debt boom reinforces Bitcoin miners' AI pivot

Cointelegraph•9h ago
← Back to News Feed